ATE354376T1 - Zusammensetzungen für die elektroporation - Google Patents

Zusammensetzungen für die elektroporation

Info

Publication number
ATE354376T1
ATE354376T1 AT00915386T AT00915386T ATE354376T1 AT E354376 T1 ATE354376 T1 AT E354376T1 AT 00915386 T AT00915386 T AT 00915386T AT 00915386 T AT00915386 T AT 00915386T AT E354376 T1 ATE354376 T1 AT E354376T1
Authority
AT
Austria
Prior art keywords
electroporation
compositions
drugs
percutaneous absorbability
elevating
Prior art date
Application number
AT00915386T
Other languages
English (en)
Inventor
Yoshihiro Tokudome
Koji Owaku
Kenichi Goto
Kenji Sugibayashi
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Application granted granted Critical
Publication of ATE354376T1 publication Critical patent/ATE354376T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00915386T 1999-10-14 2000-04-06 Zusammensetzungen für die elektroporation ATE354376T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29172199 1999-10-14

Publications (1)

Publication Number Publication Date
ATE354376T1 true ATE354376T1 (de) 2007-03-15

Family

ID=17772544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915386T ATE354376T1 (de) 1999-10-14 2000-04-06 Zusammensetzungen für die elektroporation

Country Status (8)

Country Link
US (1) US7089053B1 (de)
EP (1) EP1222932B1 (de)
JP (1) JP4868679B2 (de)
AT (1) ATE354376T1 (de)
AU (1) AU3671900A (de)
CA (1) CA2387953C (de)
DE (1) DE60033542T2 (de)
WO (1) WO2001026689A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6721595B1 (en) * 1999-10-15 2004-04-13 Pola Chemical Industries Inc. Percutaneous absorption promoters for electroporation
US8813221B1 (en) 2008-09-25 2014-08-19 Sonicwall, Inc. Reassembly-free deep packet inspection on multi-core hardware

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
JPH02468A (ja) * 1987-07-14 1990-01-05 Nisshin Flour Milling Co Ltd 乳酸桿菌に外来ｄｎａを導入する方法
DE68925030T2 (de) * 1988-01-21 1996-07-25 Massachusetts Inst Technology Molekültransport durch gewebe mit der verwendung von elektroporation.
US5069908A (en) 1989-06-19 1991-12-03 Henley International, Inc. Crosslinked hydrogel and method for making same
GB8921710D0 (en) * 1989-09-26 1989-11-08 Mentholatum Co Ltd Ibuprofen triturates and topical compositions containing same
ATE143603T1 (de) 1990-03-30 1996-10-15 Yasunori Morimoto Transdermal absorbierbares mittel mit morphin hydrochlorid
US5176918A (en) * 1990-12-20 1993-01-05 Jones Jeffry L Topical medicament
JPH0616538A (ja) 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
US5997501A (en) 1993-11-18 1999-12-07 Elan Corporation, Plc Intradermal drug delivery device
JPH10511008A (ja) * 1994-06-24 1998-10-27 シグナス， インコーポレイテッド 膜透過性制御のための電子電圧パルスを用いた生物学的活性因子のパルス使用送達システム
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US5990179A (en) 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
ATE255450T1 (de) 1995-06-09 2003-12-15 Hisamitsu Pharmaceutical Co Matrix für iontophorese
EP0748636B1 (de) 1995-06-14 2003-08-27 Hisamitsu Pharmaceutical Co., Inc. Schnittstelle für Iontophorese
JP3898250B2 (ja) * 1996-03-26 2007-03-28 久光製薬株式会社 エレクトロポレーション用マイクロエマルション製剤
EP0952850A2 (de) * 1996-12-31 1999-11-03 Altea Technologies, Inc. Mikroporation von gewebe zur bioaktive-mittel-abgabe
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
CA2330211A1 (en) * 1998-06-08 1999-12-16 Karel Petrak Formulations for electroporation
WO1999065563A1 (en) * 1998-06-19 1999-12-23 Genetronics, Inc. Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction
DK1121145T3 (da) 1998-10-16 2002-08-12 Novo Nordisk As Insulinpræparater til indgivelse via lungerne, som indeholder mentol
US6678558B1 (en) * 1999-03-25 2004-01-13 Genetronics, Inc. Method and apparatus for reducing electroporation-mediated muscle reaction and pain response

Also Published As

Publication number Publication date
US7089053B1 (en) 2006-08-08
EP1222932A1 (de) 2002-07-17
JP4868679B2 (ja) 2012-02-01
DE60033542D1 (de) 2007-04-05
AU3671900A (en) 2001-04-23
WO2001026689A1 (fr) 2001-04-19
DE60033542T2 (de) 2007-11-22
CA2387953C (en) 2008-12-09
EP1222932A4 (de) 2004-05-12
CA2387953A1 (en) 2001-04-19
EP1222932B1 (de) 2007-02-21

Similar Documents

Publication Publication Date Title
BG106440A (en) Nitrogen-heterocyclic derivatives as nos inhibitors
DK1613304T3 (da) DPP-IV-inhibitorer
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
PL366590A1 (en) Novel compounds as anti-inflammatorz, immunomodulatory and anti-proliferatory agents
PL368412A1 (en) Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
DE60031709D1 (de) Zusammensetzungen für die elektroporation
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
NO20054787L (no) Indenderivater som farmasotiske midler
UY26133A1 (es) Derivado sustituido de pirazol.
WO2005009345A3 (en) 2-desmethyl ansamycin compounds
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
DE60033542D1 (de) Zusammensetzungen für die elektroporation
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
DE59910585D1 (en) 3,4-dihydrochinolin-derivative als stickstoffmonoxid-synthase (nos) inhibitoren
ATE206125T1 (de) Furoindolizine
NO20053208L (no) Metode for reduktiv dehalogenering.
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
ATE328581T1 (de) Perkutane absorptionsbeschleuniger für die elektroporation
SG145571A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
HN1999000157A (es) 1,2,3 tetrahidroquinolinas 2 - sustituidas 4 - amino sustituidas.
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties